Close

GenMark Diagnostics (GNMK) Target Raised to $15 at Raymond James

October 2, 2013 2:17 PM EDT Send to a Friend
Raymond James maintained an Outperform on GenMark Diagnostics (NASDAQ: GNMK) and raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login